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Sterilization of heparinized Cuprophan 
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Faculty of Chemical Technology and Institute for Biomedical Technology, University of 
Twente, PO Box 217, 7500 AE Enschede, The Netherlands 
The effects of sterilization of dry heparinized Cuprophan hemodialysis membranes by 
means of ethylene oxide (EtO) exposure, gamma irradiation, or steam on the anticoagulant 
activity and chemical characteristics of immobilized heparin and the permeability of the 
membrane were investigated. Sterilization did not result in a release of heparin or heparin 
fragments from heparinized Cuprophan. Sterilization of heparinized Cuprophan by means of 
Et0 exposure and gamma irradiation induced a slight, insignificant decrease of the 
anticoagulant activity. In contrast, steam-sterilized heparinized Cuprophan showed a higher 
anticoagulant activity than unsterilized heparinized Cuprophan, which was most likely 
caused by cleavage of some of the covalent bonds between heparin and Cuprophan. The 
effects of sterilization on the permeability of unmodified Cuprophan and heparinized 
Cuprophan were compared. The permeability of unmodified Cuprophan for vitamin 
B12 (Vit B12) and sulfobromophthalein (SBP) was reduced by 20-35% after Et0 exposure and 
gamma irradiation and was reduced by 90-95% after steam sterilization. The water 
permeability of unmodified Cuprophan remained the same after Et0 exposure and gamma 
irradiation but also dramatically reduced after steam sterilization. These reductions were 
ascribed to the collapse of pores of the membrane. The permeability of heparinized 
Cuprophan was not affected by Et0 exposure and gamma irradiation but dramatically 
reduced after steam sterilization, although to a lesser extent than in the case of unmodified 
Cuprophan. Apparently, the presence of immobilized heparin (partially) prevented the 
collapse of pores during sterilization. Gamma irradiation was recommended as the preferred 
method of sterilization for heparinized Cuprophan. 
1. Introduction 
Hemodialysis is nowadays a well established therapy 
for uremic patients. The majority of these patients is 
treated with membranes made of regenerated cellu- 
lose. The main disadvantage of the application of 
cellulosic membranes for hemodialysis is their rela- 
tively poor blood compatibility. An often applied 
strategy to improve the blood compatibility of blood- 
contacting material surfaces is the immobilization of 
heparin [l-3]. In a previous study we have shown 
that heparin can be covalently immobilized onto Cu- 
prophan hemodialysis membranes by means of 
a N,N’-carbonyldiimidazole (CDI) activation proced- 
ure [4]. Cuprophan heparinized in this way indeed 
showed an improved blood compatibility. Further- 
more, the heparinization procedure hardly affected the 
permeability of the membrane for model solutes with 
a molecular weight up to 12000. 
Prior to use, hemodialysis systems require steril- 
ization. Although in some studies the effects of ster- 
ilization on the properties of non-immobilized heparin 
has been investigated [S-7], less information is 
available about the effects of sterilization on the prop- 
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erties of immobilized heparin [3, 8, 91. Furthermore, 
in several reports it is shown that sterilization can ad- 
versively affect the permeability of hemodialysis 
membranes [lo-141. Therefore, the present study was 
undertaken to investigate the effects of sterilization by 
means of three commonly used methods, Et0 expo- 
sure, gamma irradiation and steam, on the chemical 
characteristics and biological activity of heparin im- 
mobilized onto Cuprophan. Non-immobilized hepa- 
rin was used as a control. Furthermore, the effects of 
sterilization on the permeability of heparinized Cu- 
prophan were investigated. 
2. Materials and methods 
2.1. Materials 
Cuprophan 150 M was a gift from AKZO, Wuppertal, 
Germany. Formamide (synthesis grade, Merck, Darm- 
stadt, Germany) was purified according to a method 
described by Verhoek et al. [15]. Heparin (sodium 
salt) from porcine intestinal mucosa (activity: 
1655190 U/mg, Mn: 12000 g/mol) was purchased 
from Diosynth, Oss, The Netherlands. Heparin also 
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from porcine intestinal mucosa of which 55-60% of 
the sodium ions was substituted by benzyltrimethyl- 
ammonium ions (heparin triton B, Mn: 16 000 g/mol) 
was purchased from HBG, Enschede, The Nether- 
lands. Human antithrombin III (AT III, Sigma Chem- 
ical Company, St Louis, USA) was purified using 
a heparin-Sepharose column (Sigma) [16]. Bovine al- 
bumin (Alb), Vit B12, and SBP were also purchased 
from Sigma. Chromogenic substrate Szz3s was ob- 
tained from Chromogenix, Molndal, Sweden. Poly- 
ethylene glycol (6000 g/mol, PEG) was purchased 
from Fluka Chemie, Buchs, Switzerland. PTT-reagent 
was obtained from Boehringer, Mannhein, Germany. 
CPDA-1 plasma was purchased from the Rode Kruis 
Bloedbank Twente-Achterhoek, Enschede, The Neth- 
erlands. Phosphate buffered saline (pH: 7.4, PBS) was 
purchased from NPBI, Emmercompascuum, The 
Netherlands. CDI, NaCl, 1 N NaOH, 1 N HCl, 
CaClz.HzO, toluidine blue 0 zinc chloride double salt 
(toluidine blue), and tris(hydroxymethyl)-ammonium 
methane (tris) (all analytic grade) were purchased from 
Merck. All chemicals were used without further purifi- 
cation except when mentioned. 
2.2 Heparinization of Cuprophan 
Cuprophan was heparinized as described earlier [4]. 
Briefly, heparin triton B dissolved in formamide 
was activated with CDI. Thereafter, the reaction 
mixture was transferred to Cuprophan membranes. 
After immobilization, the membranes were rinsed 
with demineralized water and then incubated in an 
aqueous 4 M NaCl solution. Thereafter the mem- 
branes were again rinsed with demineralized water, 
soaked in a 10 wt % solution of glycerol in de- 
mineralized water and subsequently dried by air 
exposure for 2 days. 
The immobilization procedure yielded membranes 
with about 80 yg immobilized heparin per cm2 mem- 
brane surface area [4]. 
2.3. Sterilization 
Heparinized Cuprophan and as a control non-immo- 
bilized sodium salt of heparin were sterilized by means 
of Et0 exposure, gamma irradiation, and steam using 
the following procedures. Et0 sterilization (Griffith, 
Zoetermeer, The Netherlands): the samples were 
stored for 16 h at a relative humidity of 60% and 
a temperature of 35 “C. Subsequently, the pressure was 
reduced to 7.5 kPa. After one hour the pressure was 
elevated to 60 kPa with Et0 (850 mg/l) at 45 “C. After 
3 h, the pressure was reduced to 7.5 kPa at 40 “C and 
subsequently elevated to lo5 Pa with air. This air 
wash procedure was repeated once. Thereafter, the 
samples were stored for 3 days at 40°C. Gamma 
irradiation (Gammaster, Ede, The Netherlands): the 
samples were exposed to a 6oCo source until the 
samples received 2.3 kGy. Steam sterilization (MST, 
Enschede, The Netherlands): the samples were auto- 
claved for 30 min at 120 “C. 
All samples were sterilized in the dry state except for 
steam sterilization of non-immobilized heparin. In the 
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latter case, heparin was dissolved in water. After steril- 
ization, the solution was lyophilized. 
Prior to further testing, the membranes were incu- 
bated in PBS at 4°C for 16 h. 
2.4. Complexation of heparin in solution 
with toluidine blue 
A toluidine blue assay was developed to study the 
effects of sterilization on the degree of complexation of 
heparin in solution with toluidine blue. To 2 ml of 
a solution of sterilized heparin in aqueous 0.01 N 
HC1/0.2 wt % NaCl, 2 ml of a freshly prepared solu- 
tion of 0.04 wt % toluidine blue in aqueous 0.01 N 
HC1/0.2 wt % NaCI, was added. The mixture was 
gently shaken for 4 h during which the formed 
heparin/toluidine bide complex precipitated. Sub- 
sequently, the mixture was centrifuged at 1000 g for 
10 min after which the supernate was removed. There- 
after the precipitate was rinsed with aqueous 0.01 N 
HC1/0.2 wt % NaCl and then incubated in 5 ml of 
a 4/l (v/v) mixture of ethanol and aqueous 0.1 N 
NaOH. In this medium the heparin/toluidine blue 
complex is broken and toluidine blue dissolves. The 
extinction of the resulting solution was measured at 
530 nm against a 4/l (v/v) mixture of ethanol and 
aqueous 0.1 N NaOH. Unsterilized heparin was used 
as a control. 
2.5. Complexation of immobilized heparin 
with toluidine blue 
A toluidine blue assay as described by Smith et al. 
[ 171 and modified for our purposes was used to study 
the effects of sterilization on the degree of complexa- 
tion of heparin immobilized onto Cuprophan with 
toluidine blue. Heparinized and sterilized Cuprophan 
was cut in circular discs with a diameter of 7 mm. The 
immobilized heparin was stained by incubating the 
membrane in 5 ml of a freshly prepared solution of 
0.04 wt % toluidine blue in aqueous 0.01 N HC1/0.2 
wt % NaCl. After 4 h of gently shaking, the membrane 
was rinsed twice with demineralized water and then 
incubated into 5 ml of a 4/l (v/v) mixture of ethanol 
and aqueous 0.1 N NaOH. After complete decolouriz- 
ation of the membrane, the extinction of the fluid 
phase was measured at 530 nm against a 4/l (v/v) 
mixture of ethanol and aqueous 0.1 N NaOH. 
Unsterilized heparinized Cuprophan was used as 
a control. 
2.6. Thrombin inactivation assay 
The anticoagulant activity of sterilized non-immobi- 
lized heparin and heparin immobilized onto Cu- 
prophan was investigated by means of a thrombin 
inactivation assay. A buffer solution consisting of an 
aqueous solution of 50 mmol/l tris, 1.0 g/l PEG, 
1.0 g/l BSA, and 150 mmol NaCl adjusted to pH 8.4 
was prepared. The buffer solution was used for the 
preparation of a substrate S2238 (2.0 mg/ml)/AT III 
(70 mu/ml) solution, a thrombin solution (0.4 U/ml), 
solutions of sterilized heparin, and a series of solutions 
of untreated heparin (O-20 mu/ml). To determine 
the anticoagulant activity of sterilized heparin, 40 ~1 
of a solution of sterilized heparin was mixed with 
150 ~1 of substrate/AT III solution. To determine the 
anticoagulant activity of immobilized heparin, mem- 
branes were cut into circular discs with a diameter of 
5 mm and incubated in 150 1.11 of substrate/AT III 
solution and 40 ~1 of buffer solution. For the deter- 
mination of a calibration curve, 40 ~1 of heparin solu- 
tions of known activities were mixed with 150 ~1 of 
substrate/AT III solution. The reactions were initiated 
by adding 50 yl of the thrombin solution. The reaction 
solutions were shaken for 10 min after which the reac- 
tions were quenched by adding 70 ~1 of 40 ~01% 
acetic acid. Subsequently, the extinction of 200 ~1 
of the resulting mixture at 405 nm was determined. 
The reactions were carried out at 20°C. The calib- 
ration curve was used to determine the activity of 
heparin immobilized onto Cuprophan and sterilized 
non-immobilized heparin. 
2.7. APTT assay 
The anticoagulant activity of sterilized heparin was 
determined by means of an APTT assay. Fresh frozen 
human CPDA-1 plasma was thawed at 37°C and 
stored on ice. To 50 ~1 of a solution of sterilized 
heparin in PBS, 50 ~1 of plasma and 50 ~1 of 
PTT reagents was added. The resulting suspension 
was mixed for three minutes at 37 “C. Thereafter, 
50 ~1 of aqueous 20 mM CaCl, was added. The 
suspension was mixed again and the coagulation 
time was determined with a coagulatometer (LC-6, 
Lode, Groningen, The Netherlands). A calibration 
curve was obtained by measuring the coagulation 
time of solutions of heparin in PBS of known activities 
(O-O.7 U/ml). The calibration curve was used to 
calculate the anticoagulant activities of sterilized 
heparin. 
2.8. Permeability for Vit B12 and SBP 
The effect of sterilization and heparinization on the 
permeability of Cuprophan for Vit B1, and SBP was 
investigated using a Minitan-S ultrafiltration system 
(Millipore, Etten-Leur, The Netherlands). With a peri- 
staltic pump, feed and filtrate were circulated in such 
a way that crossflow (400 ml/min) over the mem- 
branes was obtained. At the start of the experiment 
the feed consisted of a solution of 0.02 wt % Vit B12 
and 0.02 wt % SBP in PBS and the filtrate consisted of 
PBS. The experiments were performed at 37 “C. Sam- 
ples of the filtrate were taken at different time inter- 
vals. The concentrations of Vit Blz and SBP were 
determined as follows. Vit B,,: the extinctions of the 
samples were measured at 360 nm against PBS. SBP: 
the samples were l/l (v/v) diluted with aqueous 0.01 N 
NaOH after which the extinctions of the mixtures 
were measured at 578 nm against a l/l (v/v) mixture of 
PBS and aqueous 0.01 N NaOH. Calibration curves 
were used to determine the concentrations of the 
solutes. 
The mass transfer coefficient, KO, was calculated 
using the formula as derived by Smith et al. [18]: 
- ln(AC,/AC,) = KO*Axt*(l/I/l + l/v/,) 
where AC, and AC0 are the concentration differences 
of the solutes over the membrane at times t and 0, 
respectively, A is the membrane surface area, t is the 
dialysis time, and 1/1 and 1/2 are the volumes of feed 
and dialysate, respectively. 
2.9. Water permeability 
The effect of sterilization and heparinization on the 
ultrafiltration characteristics of Cuprophan was inves- 
tigated using an Amicon 8050 ultrafiltration cell (Ami- 
con, Capelle aan de IJssel, The Netherlands). The 
ultrafiltration cell was supplied with the membrane 
under investigation and then filled with water. Sub- 
sequently, a pressure of 3 x 10’ Pa was applied. After 
l-2 h of equilibration, the water flow through the 
membrane was determined as a function of time dur- 
ing 2-4 h. 
2.10. Statistics 
The data were mutually compared by means of the 
Student t test and were considered to be significantly 
different when p < 0.05. 
3. Results and discussion 
3.1. Complexation of heparin with toluidine 
blue 
Sterilization by means of Et0 exposure, gamma ir- 
radiation, or steam did not change the complexation 
characteristics of heparin immobilized onto Cupro- 
phan or heparin in solution with toluidine blue (see 
Table I). Theoretically, Et0 can react with most of the 
functional groups of heparin [3, 191. These reactions 
can lead to a reduction of the number of negatively 
charged groups. It has been reported that gamma 
irradiation of dry heparin can result in a decrease 
of the molecular weight and a release of sulphate 
groups [S, 61. Furthermore, Menzies et al. [7] showed 
that autoclaving heparin in solution at 121 “C for 
50 min did not change the molecular weight of heparin 
or the complexation characteristics of heparin with 
azure A. 
The toluidine blue assay is based on the complexa- 
tion of toluidine blue with negatively charged groups 
of heparin. Therefore, a reduction of the number of 
negatively charged groups or chemical modification of 
TABLE I Complexation of sterilized non-immobilized and immo- 
bilized heparin with toluidine blue as compared to unsterilized 
heparin (%) 
Nonimmobilized 
heparin (n = 3) 
Immobilized 
heparin (n = 3) 
Et0 Gamma Steam 
96.8 Ji: 3.4 95.0 + 5.3 98.6 + 1.6 
105.7 k 6.3 97.6 i 3.6 89.1 + 5.0 
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these groups will affect the complexation charac- 
teristics of heparin with toluidine blue. Depolymer- 
ization of heparin does not necessarily affect the 
complexation of heparin in solution with toluidine 
blue. However, depolymerization of immobilized 
heparin or cleavage of heparin-Cuprophan linkages 
may result in a release of heparin or heparin fragments 
from the surface causing less complexed toluidine blue. 
The results show that the three different sterilization 
methods did not induce chemical modification of 
functional groups of heparin, degradation of heparin, 
or cleavage of the heparin-Cuprophan linkages to 
such an extent that complexation with toluidine blue 
was affected. 
3.2. Anticoagulant activity of heparin 
The three different sterilization methods induced a 
small but insignificant decrease of the anticoagulant 
activities of non-immobilized heparin (see Table II). 
Chemical modification of functional groups or de- 
polymerization can reduce the anticoagulant activ- 
ities of heparin [20-221. Therefore, the results of the 
thrombin inactivation and APTT assay confirm the 
conclusion of the results of the toluidine blue assay 
that these reactions did not or hardly took place 
during sterilization. Also Edwards et al. [6] found that 
the anticoagulant activities of heparin were hardly 
affected by gamma irradiation at a dose which is usually 
applied for sterilization. Furthermore, Menzies et al. 
[7] showed that autoclaving heparin in solution at 
121 “C for 50 min did not affect the anticoagulant 
activities. To our knowledge, no adverse effects of Et0 
exposure on the anticoagulant activities of heparin 
have been reported [3]. 
After Et0 and gamma sterilization, the anticoagu- 
lant activity of immobilized heparin was, like that of 
non-immobilized heparin, slightly but not signifi- 
cantly reduced (see Fig. 1). In contrast, steam steriliz- 
ation significantly increased the anticoagulant activ- 
ity. This increase can be explained as follows. The 
heparin-Cuprophan linkages established by means of 
the CDI-activation procedure may be susceptible to 
hydrolysis. Therefore, part of these linkages may be 
broken during steam sterilization. The results of the 
toluidine blue assay, however, revealed that steam 
sterilization induced no release of heparin from the 
membrane. Most likely, steam sterilization induced 
the hydrolysis of covalent linkages between heparin 
and Cuprophan but not to such an extent that heparin 
is released. As a consequence the number of covalent 
bonds between heparin and Cuprophan will be de- 
creased after steam sterilization. When heparin is im- 
mobilized via less covalent bonds, the heparin chains 
TABLE II Anticoagulant activities of sterilized non-immobilized 
heparin compared to unsterilized heparin (%) 
Et0 Gamma Steam 
Thrombin inactivation 86.6 f 8.7 84.8 f 6.8 80.1 + 17.2 
(n = 8) 
APTT (n = 8) 91.3 * 5.7 89.7 k 5.2 91.4 * 5.1 
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Figure 1 The anticoagulant activity of unsterilized and sterilized 
heparinized cuprophan as determined by means of the thrombin 
inactivation assay. 
will exhibit an enhanced mobility and more specific 
binding sites will be available for the interaction with 
AT III and factors of the coagulation cascade resulting 
in an increased anticoagulant activity [23]. 
3.3. Permeability 
Heparinization did not affect the permeability of Cu- 
prophan for Vit B12, whereas the permeability for 
SBP was substantially reduced (see Table III). This 
reduction can be ascribed to the negative charges of 
both SBP and heparin at physiological conditions by 
which the diffusion of the solute through the mem- 
brane was limited. The water permeability of Cu- 
prophan increased after heparinization. Heparin is 
most likely not only immobilized at the surface but 
also in the pores of the membrane. Immobilization of 
heparin in the pores will lead to an increased swelling 
of the membrane in water and as a consequence to an 
increased water permeability. After sterilization by 
means of Et0 exposure or gamma irradiation, the 
mass transfer coefficient of Vit B 1 2 and SBP decreased 
with 20-35% in the case of unmodified Cuprophan 
but remained the same in the case of heparinized 
Cuprophan. The net result was that after Et0 expo- 
sure or gamma irradiation, heparinized Cuprophan 
had the same or a increased permeability for SBP and 
Vit Blz. Steam sterilization caused a dramatical de- 
crease of the permeability of both types of membranes 
for the two solutes under investigation. This decrease 
was more pronounced for unmodified Cuprophan. 
The water permeability of both types of membranes 
was not affected by Et0 exposure-or gamma irradia- 
tion but dramatically decreased after steam steriliz- 
ation (see Table IV). Also in this case, this decrease 
was more pronounced for unmodified Cuprophan. 
The effects of different sterilization methods on the 
water permeability and the permeability for various 
solutes of cellulosic membranes have been studied by 
several investigators [lo-141. The results of these 
studies are not always consistent. Conflicting results 
can be ascribed to differences in pore characteristics, 
chemical structure, geometry (sheet, tubing, or fibre) of 
the membranes, experimental conditions of the per- 
meability study, and whether the membranes are ster- 
ilized in the dry or wet state or acquired a special 
TABLE III Permeability of Cuprophan, K,( x 10m3 cm/mm) 
Vit Br, (n = 3) 
Unmodified 
Heparinized 
SBP (n = 3) 
Unmodified 
Heparinized 
Unsterilized 
1.74 * 0.07 
1.78 * 0.17 
3.93 * 0.20 
2.92 k 0.20 
Et0 Gamma Steam 
1.20 &- 0.10 1.13 + 0.09 0.075 * 0.007 
1.65 f 0.28 1.55 f 0.04 0.323 + 0.032 
3.05 + 0.17 2.76 f 0.21 0.47 &, 0.01 
3.09 + 0.12 2.99 k 0.10 1.01 f 0.10 
TABLE IV Water permeability of Cuprophan in ul/h x cm’ at 
a pressure of 3 x lo5 Pa (n = 3) 
Unsterilized Et0 Gamma Steam 
Unmodified 300 * 4 319 + 6 300 k 8 63 2 6 
Heparinized 385 * 11 402+6 352+14 13Ok5 
pretreatment. In general, it has been observed that the 
permeability was not affected or maximally decreased 
with 35% after Et0 or gamma sterilization of the 
membrane in the dry state as also found in our study. 
A decreased permeability can be related to the col- 
lapse of pores of the membrane resulting in a de- 
creased porosity and swelling in water [lo, 11, 13, 141. 
A dramatical decrease of the permeability after 
steam sterilization of dry membranes has also been 
observed by Broek et al. [lo]. In this case, a severe 
collapse of the pores took place during sterilization 
[lo, 111. Takesawa et al. [14] showed that the col- 
lapse of pores can be partially prevented by steriliz- 
ation of the membrane in a wet state. For heparinized 
Cuprophan, however, steam sterilization of the mem- 
brane in a wet state cannot be recommended because 
it will result in a substantial hydrolysis of the hepa- 
rin-Cuprophan linkages. The decrease of the per- 
meability after steam sterilization can also be pre- 
vented by pretreatment of the membrane with highly 
concentrated aqueous glycerol solutions [ 111. Filling 
of the pores with glycerol prevents collapse of the 
pores during sterilization. 
After Et0 and gamma sterilization, the permeabil- 
ity of unmodified Cuprophan for Vit Blz and SBP was 
decreased whereas the permeability of heparinized 
Cuprophan for these solutes had not been changed. 
These results suggest that heparinization had a 
similar effect as high loading of the membrane 
with glycerol. As mentioned above, heparin was also 
immobilized in the pores of the membrane. Therefore, 
heparin most likely (partially) prevented the collapse 
of the pores. This effect of heparin was also evident 
for steam sterilization. After steam sterilization, 
the decrease of both the permeability for Vit Blz 
and SBP and the water permeability was more 
pronounced for unmodified Cuprophan than for 
heparinized Cuprophan. However, for clinical ap- 
plications, the decrease of the permeability of 
heparinized Cuprophan by steam sterilization is still 
unacceptable. 
4. Conclusions 
The effects of sterilization of dry heparinized Cu- 
prophan by means of Et0 exposure, gamma irra- 
diation, or steam on’the anticoagulant activity and 
chemical characteristics of heparin and the permeabil- 
ity of the membrane were investigated. Sterilization by 
means of the three different methods did not adver- 
sively affect the anticoagulant activity of immobilized 
heparin. After Et0 exposure or gamma irradiation, 
the permeability of heparinized Cuprophan had the 
same or a increased permeability as compared to 
unmodified Cuprophan. A decreased permeability of 
unmodified Cuprophan was ascribed to the collapse of 
pores. In the case of heparinized Cuprophan, collapse 
of the pores was prevented most likely because hepa- 
rin is immobilized in the pores. Steam sterilization 
caused a dramatical decrease of the permeability of 
both heparinized and unmodified Cuprophan ren- 
dering these membranes unsuitable for clinical 
hemodialysis treatment. Therefore, Et0 exposure and 
gamma irradiation seem suitable methods of sterili- 
zation of heparinized Cuprophan. In numerous re- 
ports, however, it has been shown that Et0 sterilized 
materials can induce severe toxic effects [24-271. 
Remnants of Et0 can give rise to high levels of anti 
Et0 IgE antibodies resulting in anaphylactic reactions. 
Therefore, with respect to the properties of immobi- 
lized heparin and the permeability of the membrane 
we recommend gamma irradiation for sterilization of 
heparinized Cuprophan for clinical applications. 
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